HomeOpen Access News

Open Access News

Breakthrough Obe-cel drug for aggressive leukaemia to reach NHS patients

A new immunotherapy for a severe form of blood cancer will soon be available on the NHS, offering new hope to adults whose disease has returned or stopped responding to conventional treatment.

How the retreat of big pharma leads to lost opportunities for Parkinson’s drug discovery

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will...

How will General Data Protection Regulation (GDPR) affect your business?

For consumers, new data protection legislation offers increased privacy, but how will GDPR affect your business? The Information Commissioner’s Office explains The General Data Protection...

Ebenstein lab develops new technologies for studying genomes

Researchers in the Ebenstein lab for nanobiophotonics at Tel Aviv University are using epigenetic marks to study genomic variation Although the DNA sequence is identical...

Innovative oncology drug development: Why not children?

SIOPE asks why therapies made available for adults are not extended to children with cancer, and why paediatric oncology drug development is lagging behind Thanks...

SMEs have a vital role to play in the pharmaceutical field

Dr. Alexander Natz and Dr. Oliver Sude, EUCOPE outline the role small to medium sized innovative companies can play in developing pharmaceutical research

Engineers warn of Brexit threat to UK nuclear industry

The Institution of Mechanical Engineers calls for the government to make clear transitional arrangements to protect the UK nuclear industry after Brexit A new report...

Assessing the risk to engineering materials from water impact

Mark Gee, Fellow at the National Physical Laboratory, is exploring new ways to assess and reduce erosion in engineering materials from water impact It seems...

Cities are at the heart of European democracy

Daniël Termont, Mayor of Ghent and current EUROCITIES president, outlines why cities are central to European democracy and how they can solve modern problems The...

Umbilical cord blood: A life enhancer for all babies

Judith Mercer and Debra-Erickson Owens have found positive changes after a short delay in cord clamping, indicating the benefits of umbilical cord blood When cord...

POLAR: Investigating the issues Arctic communities face

Polar Knowledge Canada, a new federal organisation, brings together indigenous and scientific expertise to look at the issues Arctic communities face today Polar Knowledge Canada...

New National Cyber Security Centre opened by The Queen

Her Majesty The Queen officially opened the UK’s National Cyber Security Centre HQ in London today The NCSC, as part of GCHQ, is tasked with...

Developing and serving the climate services market

Professor Dr Daniela Jacob and colleagues at GERICS seek a better understanding of the climate services market and how to contribute to its development Responding...

Out of sight: Low vision is a National Eye Institute priority

Low vision can be a blight on the lives of those it affects, which is why it’s a National Eye Institute priority, as Dr...

Council boycotts of Israeli goods will become illegal

The UK government plans to make local council boycotts of countries and companies – particularly Israel – illegal, in new measures announced this week Communities...

Harnessing the power of the electronic signature

Qualified electronic signature solutions can provide security and efficiency, as Comsign Europe explain According to Gartner, Inc., 6.4 billion connected things will be in use...

Optimising the menstrual cycle: Fact not fiction

Researchers at the Human Performance Laboratory are separating the fact from the fiction when it comes to optimising the menstrual cycle of female athletes Athletes,...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders